8:00 AM - 9:15 AM
About the New Frontiers in Precision Population Health & Health Equity Seminar Series
Across the globe, we are plagued by significant health inequalities: low-income populations suffer from many more health issues than wealthier populations, and profound racial inequalities persist, amplified and reinforced by the COVID-19 pandemic. The New Frontiers in Precision Population Health and Health Equity Seminar Series aims to bring together public health professionals, policymakers, academics, and industry collaborators to explore how a precision population approach can be utilized to advance health equity for marginalized populations. While precision medicine has significantly advanced patient care, reducing health disparities at the population-level requires a precision population approach. This approach must leverage big data, AI, and digital innovations to create very targeted population health policies and interventions that can dramatically improve the health of underserved communities.
Harnessing Digital Technologies to Advance Global Precision Health and Development
A New Frontiers in Precision Population Health & Health Equity Seminar Series Event
Digital technologies have the potential to significantly reduce global health and development inequalities. As part of the New Frontiers in Precision Population Health and Health Equity Seminar Series, our upcoming panel session will explore:
- How innovative digital technologies (e.g., drones, AI-enabled screening tools) are being used to develop more precise and effective global health and development policies and interventions
- Potential for digital technologies to help manage the COVID-19 crisis in India
- Opportunities for, and limitations of, digital technologies to facilitate global health and economic equity
- Future directions in digital health technologies and precision health and development
Professor of Medicine (Infectious Diseases) and Senior Fellow at the Woods Institute and the Freeman Spogli Institute and Professor, by courtesy, of Epidemiology and Population Health, Stanford University
Dr. Luby is a is a physician, epidemiologist and researcher who lived and worked in Pakistan for 5 years and in Bangladesh for 8 years. He has led research teams who have advanced global scientific understanding of: hepatitis C transmission and safe injections; water, sanitation and handwashing; Nipah virus epidemiology and prevention; typhoid fever epidemiology and prevention and low cost approaches to disease surveillance.
Brigitte Gosselink, Keynote Speaker
Director of Product Impact, Google.org
Brigitte Gosselink leads Google.org’s work to leverage emerging technologies and Google’s expertise to address global challenges. She is currently focused on how AI can be used for social impact through efforts such as the $25M Google AI Impact Challenge, with a particular focus on crisis response and sustainability. She previously created programs focused on how technology can improve global education and innovation for people with disabilities. Prior to Google.org, Brigitte was a strategy consultant for nonprofits and foundations at The Bridgespan Group, and she worked for the U.S. Agency for International Development and IRD, focusing on innovative approaches in post-conflict transitions. She has an MBA from the Yale School of Management and a BS in Systems Engineering from the University of Virginia.
Giulio De Leo
Professor of Biology and Senior Fellow at the Woods Institute for the Environment, Stanford University
Giulio De Leo is a disease ecologist interested in investigating factors and processes driving the dynamics of coupled natural and human systems and in using this knowledge to identify levers for health and conservation, i.e., ecological interventions that can improve human wellbeing and the health of the environment that underpins it. In the last ten years, he has been particularly interested in investigating how the development of water management infrastructures to support agricultural expansion and intensification may increase the risk of transmission of schistosomiasis, one of the most important of the so called Neglected Tropical Diseases.
Along with Dr. Sokolow, Dr. De Leo co-founded “The Upstream Alliance: partners in schistosomiasis reduction” and the Stanford Program for Disease Ecology, Health and the Environment, with the goal of developing ecological solutions to control infectious diseases with an important environmental component in their transmission cycle.
Managing Director, Programs, Health Initiative
The Rockefeller Foundation
Manisha Bhinge joined the Rockefeller Foundation in October 2016 and serves as a Managing Director for Health. Manisha leads program strategy and manages the portfolio of global partners for the Rockefeller Foundation’s Precision Public Health Initiative, and, more recently, pandemic response and prevention efforts. She has over a decade and a half of experience in social innovation and implementation science in global health. Prior to this role, she created and led the strategic partnerships office at Tata Trusts, India’s oldest philanthropic organization, and launched The India Health Fund, a leverage fund in collaboration with the Global Fund. In addition, Manisha was Vice President for over six years at BRAC, the world’s largest NGO, where she developed and managed programs that promote access to health, education, economic empowerment and social justice. She has worked extensively across Africa and South Asia on community-based service delivery and women’s health and empowerment.